Technology | April 02, 2013

Opal-Mammo Suite supports DBT, eliminating need for a stand-alone viewing system

Viztek Opal-Mammo PACS Mammography systems Breast imaging workstations

April 2, 2013 — Viztek is one of the first picture archive and communications service (PACS) vendors to provide viewing capabilities for digital breast tomosynthesis (DBT) imaging. With the addition of this capability to Viztek’s Opal-Mammo software suite, hospitals and imaging centers now have a choice of the viewing software they select for use with their DBT system. Further, because the mammography suite offers integrated tracking software, facilities additionally benefit from the use of one workstation and an automated workflow for a faster, streamlined approach for mandatory MQSA reporting.

“The introduction of new modalities such as digital breast tomosynthesis require advanced viewing systems for diagnosis, and the Opal-Mammo Suite from Viztek is an example of our ability to quickly respond to industry needs and deliver high quality tools,” said Josip Cermin, president of Viztek. “As we continue to expand our product offerings, hospitals and imaging centers alike can expect to see Viztek be first to market with other software and digital system innovations.”

With the addition of digital breast tomosynthesis diagnostic viewing capabilities from Viztek, facilities implementing the DBT screening modality now have a choice of viewing workstations. Viztek’s fully MQSA-compliant Opal-Mammo Suite enables users to establish customized rules for patient follow-up and closes the loop on all communications involved. Radiologists can declare specific triggers for each patient as they review exams based on specific findings. A turnaround time (TAT) management dashboard uses color-coding and reviews time parameters to manage priority levels for patients.

Additionally, the Viztek Opal-Mammo Suite is the first system to combine PACS with linked patient tracking software in a Web-based mammography viewer, which not only allows a seamlessly integrated workflow but eliminates the need for a separate tracking system to be purchased and integrated. This enables a streamlined workflow while eliminating the need for additional capital and maintenance costs involved with contracting a third party vendor.

“Our mammographers need the best viewing tools to support their diagnosis and detect the subtle details that can be cancers, and so we were happy to have a choice for our digital breast tomosynthesis viewer and use the Opal-Mammo Suite from Viztek,” said Masoud Vahdatpour of Cyrus Diagnostic Imaging in Lake Mary, Fla. “Combined with the integrated mammography tracking capabilities, the Opal-Mammo Suite meets our needs for both high quality image viewing and high efficiency, making the process of viewing and evaluating the images more fluid and allowing us to provide the highest standard of patient care.”

For more information: visitwww.viztek.net


Related Content

News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Feature | Information Technology | Dhruv Chopra

Radiology is a cornerstone of modern medical diagnostics, but today it stands at an inflection point. Pressures ...

Time February 24, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Enterprise Imaging

Feb. 12, 2026 — Agfa HealthCare continued its strong business momentum across the U.S. market, as health systems expand ...

Time February 20, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
Subscribe Now